OBJECTIVE:To observe clinical efficiency of pamidronate disodium (bolin) for the treatment of multiple myeloma (MM) with ostalgia.

观察帕米膦酸二钠(博宁)对多发性髓痛的临床疗效。

Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome.

来那度胺是一种新型免疫调节药,主要用于治疗多发性髓和髓增生异常。

In most cases of chronic urticaria, an underlying trigger is not found. Hodgkin's disease may be accompanied by urticaria. Cold urticaria with cryoglobulinemia is seen in multiple myeloma.

在大多数慢性荨麻疹患者，找不到触发原因。霍杰金氏病可伴有荨麻疹；冷球蛋白血症引起的荨麻疹见于多发性髓。

OBJECTIVE:To observe clinical efficiency of pamidronate disodium (bolin) for the treatment of multiple myeloma (MM) with ostalgia.

观察帕米膦酸二钠(博宁)对多发性髓瘤痛的临床疗效。

Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome.

来那度胺是一种新型免疫调节药,主要用于治疗多发性髓瘤和髓增生异常综合征。

In most cases of chronic urticaria, an underlying trigger is not found. Hodgkin's disease may be accompanied by urticaria. Cold urticaria with cryoglobulinemia is seen in multiple myeloma.

在大多数慢性荨麻疹患者，找不到触发原因。霍杰金氏病可伴有荨麻疹；冷球蛋白起的荨麻疹见于多发性髓瘤。

OBJECTIVE:To observe clinical efficiency of pamidronate disodium (bolin) for the treatment of multiple myeloma (MM) with ostalgia.

观察帕米膦酸二钠(博宁)对多发性髓瘤痛的临床疗效。

Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome.

来那度胺是一种新型免疫调节药,主要用于治疗多发性髓瘤和髓增生异常综合征。

In most cases of chronic urticaria, an underlying trigger is not found. Hodgkin's disease may be accompanied by urticaria. Cold urticaria with cryoglobulinemia is seen in multiple myeloma.

在大多数慢性荨麻疹患者，找不到触发原因。霍杰金伴有荨麻疹；冷球蛋白血症引起的荨麻疹见于多发性髓瘤。

OBJECTIVE:To observe clinical efficiency of pamidronate disodium (bolin) for the treatment of multiple myeloma (MM) with ostalgia.

观察帕米膦酸二钠(博宁)对多发性髓痛的临床疗效。

Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome.

来那度胺是一种新型免疫调节药,主要用于治疗多发性髓和髓增生异常综合征。

In most cases of chronic urticaria, an underlying trigger is not found. Hodgkin's disease may be accompanied by urticaria. Cold urticaria with cryoglobulinemia is seen in multiple myeloma.

在大多数慢性荨麻疹，不到触发原因。霍杰金氏病可伴有荨麻疹；冷球蛋血症引起的荨麻疹见于多发性髓。

OBJECTIVE:To observe clinical efficiency of pamidronate disodium (bolin) for the treatment of multiple myeloma (MM) with ostalgia.

观察帕米膦酸二钠(博宁)对多发性髓瘤痛的临床疗效。

Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome.

来那度胺是一种新型免疫调节药,主要用于治疗多发性髓瘤和髓增生异常综合征。

In most cases of chronic urticaria, an underlying trigger is not found. Hodgkin's disease may be accompanied by urticaria. Cold urticaria with cryoglobulinemia is seen in multiple myeloma.

在大多数慢性荨麻疹患者，找不到触发原因。霍杰金氏有荨麻疹；冷球蛋白血症引起的荨麻疹见于多发性髓瘤。

OBJECTIVE:To observe clinical efficiency of pamidronate disodium (bolin) for the treatment of multiple myeloma (MM) with ostalgia.

观察帕米膦酸二钠()多发性髓瘤床疗效。

Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome.

来那度胺是一种新型免疫调节药,主要用于治疗多发性髓瘤和髓增生异常综合征。

In most cases of chronic urticaria, an underlying trigger is not found. Hodgkin's disease may be accompanied by urticaria. Cold urticaria with cryoglobulinemia is seen in multiple myeloma.

在大多数慢性荨麻疹患者，找不到触发原因。霍杰金氏病可伴有荨麻疹；冷球蛋白血症引起荨麻疹见于多发性髓瘤。

OBJECTIVE:To observe clinical efficiency of pamidronate disodium (bolin) for the treatment of multiple myeloma (MM) with ostalgia.

观察帕米膦酸二钠(博宁)对多发性髓瘤痛的临床疗效。

Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome.

来那度胺是一种新型免疫调节药,主要用于治疗多发性髓瘤和髓增生异常综合征。

In most cases of chronic urticaria, an underlying trigger is not found. Hodgkin's disease may be accompanied by urticaria. Cold urticaria with cryoglobulinemia is seen in multiple myeloma.

在大多数慢性荨麻疹患者，找不到触发原因。霍杰金氏病可伴有荨麻疹；冷球症引起的荨麻疹见于多发性髓瘤。

OBJECTIVE:To observe clinical efficiency of pamidronate disodium (bolin) for the treatment of multiple myeloma (MM) with ostalgia.

观察帕米膦酸二钠(博宁)对多发性髓瘤痛的临床效。

Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome.

来那度胺是一种新型免疫调节药,主要用于治多发性髓瘤和髓增综合征。

In most cases of chronic urticaria, an underlying trigger is not found. Hodgkin's disease may be accompanied by urticaria. Cold urticaria with cryoglobulinemia is seen in multiple myeloma.

在大多数慢性荨麻疹患者，找不到触发原因。霍杰金氏病可伴有荨麻疹；冷球蛋白血症引起的荨麻疹见于多发性髓瘤。

OBJECTIVE:To observe clinical efficiency of pamidronate disodium (bolin) for the treatment of multiple myeloma (MM) with ostalgia.

观察帕米膦酸二钠(博宁)对多发性髓瘤痛的临床疗效。

Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome.

来那度胺是一种新型免疫调节药,主要用于治疗多发性髓瘤和髓增生异常综合征。

In most cases of chronic urticaria, an underlying trigger is not found. Hodgkin's disease may be accompanied by urticaria. Cold urticaria with cryoglobulinemia is seen in multiple myeloma.

在大多数慢性患者，找不到触发原因。霍杰金氏可伴有；冷球蛋白症引起的见于多发性髓瘤。

OBJECTIVE:To observe clinical efficiency of pamidronate disodium (bolin) for the treatment of multiple myeloma (MM) with ostalgia.

观察帕米膦酸二钠(博宁)对多髓瘤痛的临床疗效。

Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome.

来那度胺是一种新型免疫调,要用于治疗多髓瘤和髓增生异常综合征。

In most cases of chronic urticaria, an underlying trigger is not found. Hodgkin's disease may be accompanied by urticaria. Cold urticaria with cryoglobulinemia is seen in multiple myeloma.

在大多数慢荨麻疹患者，找不到触原因。霍杰金氏病可伴有荨麻疹；冷球蛋白血症引起的荨麻疹见于多髓瘤。